Evolution of the Average Target: Vertex, Inc.

Evolution of the Target Price: Vertex, Inc.

Changes in Analyst Recommendations: Vertex, Inc.

ec2e2b89.h9PHa6NRyHm5P7J8BpX1C_gRoRgO16UaCw_036yqoDs.4oOrWuZ8hFSNa9M7c8aEM8tAxEJhgdUrc3W6qc6TzUjR4_AP8yiwNeF05w~4e662313bcdc8521ba138d5b9ec65138
07-21 Vertex Facing Uncertain Growth Path Amid AI Fears, Morgan Stanley Says MT
07-21 Morgan Stanley Downgrades Vertex to Equalweight From Overweight Adjusts PT to $15 From $19 MT
07-21 Morgan Stanley Downgrades Vertex to Equalweight From Overweight, Cuts Price Target to $15 From $19 MT
07-21 Analyst recommendations: Gilead, Salesforce, Goldman Sachs, Carvana, Crowdstrike… Zonebourse
06-29 TD Cowen Initiates Vertex at Buy With $14 Price Target MT
02-12 Vertex Shares Fall After Jefferies Downgrade MT
02-12 Jefferies Downgrades Vertex to Hold From Buy, Adjusts Price Target to $16 From $28 MT
02-12 Morgan Stanley Cuts Price Target on Vertex to $20 From $33, Keeps Overweight Rating MT
02-12 Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap… Zonebourse
02-03 Piper Sandler Downgrades Vertex to Neutral From Overweight MT
11-03 (VERX) Vertex Expects 2025 Revenue Range $745.7M to $749.7M, vs. FactSet Est of $752.3M MT
25-10-21 Vertex, Inc. Announces Executive Changes CI
25-10-21 Vertex, Inc. Announces CEO Changes CI
25-10-14 Vertex, Inc. Achieves Oracle Validated Integration for Delivering A Proven, Repeatable Integration for Oracle's ERP Solution CI
25-09-26 Stephens Initiates Vertex at Overweight With $30 Price Target MT
25-06-17 Piper Sandler Initiates Coverage on Vertex With Overweight Rating, $48 Price Target MT
25-04-22 BNP Paribas Exane Initiates Coverage on Vertex With Outperform Rating, $54 Price Target MT
25-02-28 Stifel Downgrades Vertex to Hold From Buy, Adjusts Price Target to $31 From $58 MT
25-02-28 Morgan Stanley Lowers Price Target on Vertex to $57 From $62, Keeps Overweight Rating MT
25-01-03 Raymond James Downgrades Vertex to Market Perform From Outperform MT
24-12-31 DA Davidson Initiates Vertex at Buy With $62 Price Target MT
24-11-13 Morgan Stanley Raises Price Target on Vertex to $62 From $50, Keeps Overweight Rating MT
24-11-04 Jefferies Upgrades Vertex to Buy, Price Target is $50 MT
24-07-23 Baird Initiates Coverage on Vertex With Outperform Rating, $43 Price Target MT
24-04-23 Citigroup Adjusts Price Target on Vertex to $32 From $34, Keeps Neutral Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - -
+40.01%
+38.04%
+13.5%
+14.89%
+3.02%
+44.96%
+33.88%
+20.43%
+25.9%
Average +26.07%
Weighted average by Cap. +37.09%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
11.05USD
Average target price
17.46USD
Spread / Average Target
+58.02%
High Price Target
25.00USD
Spread / Highest target
+126.24%
Low Price Target
14.00USD
Spread / Lowest Target
+26.70%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Morgan Stanley
TD Cowen
Jefferies & Co.
Piper Sandler
Stephens Inc.
BNP Paribas Exane
Stifel Nicolaus
Raymond James
DA Davidson
Citigroup
BofA Securities
JMP Securities
Goldman Sachs
BMO Capital
Needham & Co.
Berenberg Bank
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
11.05USD
Average target price
17.46USD
Spread / Average Target
+58.02%

Quarterly revenue - Rate of surprise